Loading...

GALERA THERAPEUTICS INC Company Mergers 8-K Filing

GLR

GALERA THERAPEUTICS INC

()

2025 8-K

Annual Meeting Notice

Preferred Stock Amendment

Executive Bonus Agreement

Asset Sale Agreement

Asset Sale Agreement

Royalty Agreement Update

Agreement Amendment

Acquisition Completed

Director Elections

External Links:

On December 30, 2024, Galera Therapeutics, Inc. completed its acquisition of Nova Pharmaceuticals, Inc. and received SEC approval to omit certain financial statements related to the acquisition.

AI Assistant

GALERA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.